Clinical Trial Update: Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial of topical PluroGel N for mildly infected diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Infection
• Diabetic Foot Ulcer

Drugs mentioned

• PluroGel N

Snippet

Sponsor: PluroGen Therapeutics, Inc | Conditions: Diabetic Foot Ulcer, Infection | Phase 2 | Status: COMPLETED